Recent publications on Cancer

Carney PA, Cook AJ, Miglioretti DL, Feig SA, Bowles EA, Geller BM, Kerlikowske K, Kettler M, Onega T, Elmore JG. Use of clinical history affects accuracy of interpretive performance of screening mammography.  J Clin Epidemiol. 2012 Feb;65(2):219-30. Epub 2011 Oct 15. PubMed

Hubbard R, Kerlikowske K, Buist D, Yankaskas B. Evaluation of breast cancer screening strategies must be based on comparison of harms and benefits.  AJR Am J Roentgenol. 2011;197(4):W793. PubMed

Malone KE, Daling J, Doody DR, O'Brien CA, Resler AJ, Ostrander EA, Porter PL. Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer.  Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2560-71. doi: 10.1158/1055-9965.EPI-11-0781. Epub 2011 Sep 29. PubMed

Furstenau DK, Mitra N, Wan F, Lewis R, Feldman MD, Fraker DL, Guvakova MA. Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. Breast Cancer Res Treat. 2011 Sep;129(2):361-72. doi: 10.1007/s10549-010-1227-y. Epub 2010 Oct 26. PubMed

Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, Antoniou AC, Peock S, Evans DG, Paterson J, Kennedy MJ, Donaldson A, Dorkins H, Easton DF; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Rubinstein WS, Daly MB, Isaacs C, Nevanlinna H, Couch FJ, Andrulis IL, Freidman E, Laitman Y, Ganz PA, Tomlinson GE, Neuhausen SL, Narod SA, Phelan CM, Greenberg R, Nathanson KL. Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes. Cancer Res. 2011 Sep 1;71(17):5792-805. doi: 10.1158/0008-5472.CAN-11-0773. Epub 2011 Jul 28. PubMed

Pocobelli G, Doherty JA, Voigt LF, Beresford SA, Hill DA, Chen C, Rossing MA, Holmes RS, Noor ZS, Weiss NS. Pregnancy history and risk of endometrial cancer. Epidemiology. 2011 Sep;22(5):638-45. doi: 10.1097/EDE.0b013e3182263018. PubMed

Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP. Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2120-6. Epub 2011 Aug 30. PubMed

Moyer VA, U.S. Preventive Services Task Force. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2011 Aug 16;155(4):246-51. Erratum in: Ann Intern Med. 2011 Sep 20;155(6):408. PubMed

Livingston RB, Barlow WE, Kash JJ, Albain KS, Gralow JR, Lew DL, Flaherty LE, Royce ME, Hortobagyi GN. SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.  Breast Cancer Res Treat. 2011 Nov;130(1):123-31. Epub 2011 Aug 9. PubMed

Fenton JJ, Abraham L, Taplin SH, Geller BM, Carney PA, D'Orsi C, Elmore JG, Barlow WE. Effectiveness of computer-aided detection in community mammography practice.  J Natl Cancer Inst. 2011;103(15):1152-1161. Epub 2011 Jul 27. PubMed

Perdue DG, Henderson JA, Garroutte E, Bogart A, Wen Y, Goldberg J, Buchwald D. Culture and colorectal cancer screening on three American Indian reservations. Ethn Dis. 2011 Summer;21(3):342-8. PubMed

Brunner RL, Wactawski-Wende J, Caan BJ, Cochrane BB, Chlebowski RT, Gass ML, Jacobs ET, Lacroix AZ, Lane D, Larson J, Margolis KL, Millen AE, Sarto GE, Vitolins MZ, Wallace RB. The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer. 2011;63(6):827-41. Epub 2011 Jul 20. PubMed

Dillard AJ, Ubel PA, Smith DM, Zikmund-Fisher BJ, Nair V, Derry HA, Zhang A, Pitsch RK, Alford SH, McClure JB, Fagerlin A. The distinct role of comparative risk perceptions in a breast cancer prevention program. Ann Behav Med. 2011 Oct;42(2):262-8. PubMed

Roth MY, Elmore JG, Yi-Frazier JP, Reisch LM, Oster NV, Miglioretti DL. Self-detection remains a key method of breast cancer detection for U.S. women. J Womens Health. 2011 Aug;20(8):1135-9. Epub 2011 Jun 15. PubMed

Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, Knudsen AB, van Ballegooijen M, Savarino JE, Feuer EJ, Zauber AG. A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression.  Med Decis Making. 2011 Jul-Aug;31(4):530-9. Epub 2011 Jun 14. PubMed

van Ballegooijen M, Rutter CM, Knudsen AB, Zauber AG, Savarino JE, Lansdorp-Vogelaar I, Boer R, Feuer EJ, Habbema JD, Kuntz KM. Clarifying differences in natural history between models of screening: the case of colorectal cancer.  Med Decis Making. 2011 Jul-Aug;31(4):540-9. Epub 2011 Jun 14. PubMed

Checkoway H, Ray RM, Lundin JI, Astrakianakis G, Seixas NS, Camp JE, Wernli KJ, Fitzgibbons ED, Li W, Feng Z, Gao DL, Thomas DB. Lung cancer and occupational exposures other than cotton dust and endotoxin among women textile workers in Shanghai, China. Occup Environ Med. 2011 Jun;68(6):425-9. doi: 10.1136/oem.2010.059519. Epub 2010 Dec 3. PubMed

Fagerlin A, Dillard AJ, Smith DM, Zikmund-Fisher BJ, Pitsch R, McClure JB, Greene S, Alford SH, Nair V, Hayes DF, Wiese C, Ubel PA. Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.  Breast Cancer Res Treat. 2011 Jun;127(3):681-8. Epub 2011 Mar 26. PubMed

Miglioretti DL, Houssami N. Screening mammography in breast cancer survivors. J Oncol Nav Surv. 2011 May;2(3):24-5. PubMed

Onega T, Cook A, Kirlin B, Shi X, Alford-Teaster J, Tuzzio L, Buist DS. The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography.  Breast Cancer Res Treat. 2011 Aug;129(1):269-75. Epub 2011 May 7. PubMed